FacebookTwitterGoogle+RedditEmail

The War on Us

by FRED GARDNER

 

The damage wreaked by products and procedures foisted on the American people by pharmaceutical and “health care” corporations is incalculable. This week the Journal of the American Medical Association published a study showing that 300,000 unnecessary back surgeries are performed each year. The gratuitous operations are sold by surgeons on the basis of a flat-out lie, i.e., that doing nothing can result in permanent nerve damage and possible loss of bowel or bladder control. No such outcomes were reported in the large study led by James Weinstein, MD, a professor of orthopedic surgery at Dartmouth.

Weinstein’s team looked at some 2,000 patients who had been diagnosed at pain clinics with sciatica -pain from ruptured disks that typically shoots down a leg- and compared the results of those who opted for surgery with those who chose to wait for the pain to recede on its own. After two years, 70% in each group reported significantly reduced pain. Gina Kolata of the New York Times, who reported on the JAMA study Nov. 22, implied that the side effects were equivalent: “No one who waited had serious consequences, and no one who had surgery had a disastrous result.” Surgery -even surgery deemed successful – is a serious consequence unto itself and is frequently mentioned as a source of pain by Californians seeking physician approval to medicate with cannabis.

A Times story by Gardiner Harris Nov. 23 put a number on how many children and teenagers in this country have been prescribed a mix of psychiatric drugs: “Last year in the United States, about 1.6 million children and teenagers – 280,000 of them under age 10 – were given at least two psychiatric drugs in combination, according to an analysis performed by Medco Health Solutions at the request of The New York Times. More than 500,000 were prescribed at least three psychiatric drugs. More than 160,000 got at least four medications together, the analysis found.”

No studies show the combinations to be effective. According to Harris, “A 2003 review in The American Journal of Psychiatry found only six controlled trials of two-drug combinations. Four of the six failed to show any benefit; in a fifth, the improvement was offset by greater side effects. If the evidence for two-drug combinations is minimal, for three-drug combinations it is nonexistent, several top experts said.”

Bribes from the pharmaceutical corporations are being redirected towards Democrats, according to Robert Pear of the Times, whose Nov. 24 story didn’t put it quite that way. CEOs from all the major pharmaceutical corporations jetted to Washington to plot their post-election strategy. One of their key goals is to prevent the government from negotiating lower prices for Medicare recipients. Expect an excess of TV ads in which earnest elders of all ethnicities express gratitude for the existing “benefit.” The ads will be just the visible tip of a lobbying-campaign aimed at maintaining high drug prices, off-label prescribing, liability protection for vaccine makers, and direct-to-consumer advertising of their products.

Pear gives several examples of drug companies hiring well-connected Democrats. Nancy Pelosi’s former chief-of-staff has gone to work for Merck, an aide to liberal Rep. Jim McDermott of Washington signed on with Amgen etc., etc. (The misleading headline said “Drug Industry Is on Defensive As Power Shifts.” ) Pear doesn’t mention that Patton Boggs, the lobbying firm that has advanced Big Pharma’s interests throughout the Bush era, has tight connections to the Democratic Party. Its cofounder, Tommy Boggs, is a former Democratic governor of Louisiana (and bother of Cokie Roberts, and son of the late majority leader of the House, Hale Boggs who pushed through mandatory-minimum sentencing for drug-related offenses in the 1950).

In a 2003 TV interview Boggs told Robert Novak why he became a lobbyist: “Somebody had to make the money in the family, Bob. You know, it came naturally to me. I love Washington. I love politics.” Boggs bemoaned the fact that Democrats and Republicans don’t socialize as much as they used to. Novak said, “I notice that there was a fund- raiser for your fellow lobbyist, Haley Barbour, running for governor of Mississippi as a Republican, fund-raiser a few weeks ago in Washington, and I looked down the list of hosts and I found one Democrat, and it was Tommy Boggs. Does that get you in trouble with your fellow Democrats?”

Boggs replied, “I certainly primarily support Democrats. But whenever I see a Republican who I think is very competent and very good, particularly one who’s a good friend of mine, like Haley Barbour, I tend to try to help them. Mississippi’s going to have one heck of a governor”

Does Patton Boggs lobby to maintain the marijuana prohibition? Pot Shots recently heard from a reader in Colorado who sought “a very definite example of pharmaceutical company intervention into the restriction of medical marijuana -a leaked memo, personal account of lobbyist, congressional hearing testimony, etc. It seems that the argument for restriction of marijuana due to pharma interests would be much more powerful if a few hard fact, documented cases existed”

Our response: The “smoking gun” you’re asking for could probably be found in Washington, DC, without much difficulty. (I’m based in Alameda, California.) A resourceful private investigator like Terry Lenzner could probably provide the evidence you seek for about $40K. It says a lot about the big “reform” bureaucracies -the Drug Policy Alliance, the Marijuana Policy Project- that they’ve never investigated the role Big Pharma plays in maintaining Prohibition… Two senior Johnson & Johnson operatives were present at the emergency meetings held in DC by federal officials, California law enforcers and Drug War strategists (from nonprofits and think tanks) after Prop 215 passed to plan countermoves. One of them was quoted revealingly in notes taken by a California cop. Pat McCartney wrote about it in O’Shaughnessy’s.

The circumstantial evidence is not to be ignored. To the question: “Do drug companies go to great lengths to suppress competition?” we can answer yes, resoundingly. Wyeth, for example, is currently spending millions to sic the FDA on compounding pharmacists who imply that “natural” hormones from yams and other plants are preferable to synthetic premarin. And think of all the INSANE studies SSRI makers have conducted looking for some tiny marketing niche vis-à-vis the competition, i.e., so they can claim ‘Paxil has fewer side effects among the elderly,’ or some such bullshit based on some ‘stastically significant’ handful of test subjects.

Alex Cockburn once wrote, “History is one big smoking gun and the function of the official press is to say this isn’t so.”

FRED GARDNER is the editor of O’Shaughnessy’s Journal of the California Cannabis Research Medical Group. He can be reached at: fred@plebesite.com

 

 

Fred Gardner is the managing editor of O’Shaughnessy’s. He can be reached at fred@plebesite.com

More articles by:

CounterPunch Magazine

minimag-edit

Weekend Edition
September 23, 2016
Friday - Sunday
Andrew Levine
The Meaning of the Trump Surge
Jeffrey St. Clair
Roaming Charges: More Pricks Than Kicks
Mike Whitney
Oh, Say Can You See the Carnage? Why Stand for a Country That Can Gun You Down in Cold Blood?
Chris Welzenbach
The Diminution of Chris Hayes
Vincent Emanuele
The Riots Will Continue
Rob Urie
A Scam Too Far
Pepe Escobar
Les Deplorables
Patrick Cockburn
Airstrikes, Obfuscation and Propaganda in Syria
Timothy Braatz
The Quarterback and the Propaganda
Sheldon Richman
Obama Rewards Israel’s Bad Behavior
Libby Lunstrum - Patrick Bond
Militarizing Game Parks and Marketing Wildlife are Unsustainable Strategies
Andy Thayer
More Cops Will Worsen, Not Help, Chicago’s Violence Problem
Louis Yako
Can Westerners Help Refugees from War-torn Countries?
David Rosen
Rudy Giuliani & Trump’s Possible Cabinet
Joyce Nelson
TISA and the Privatization of Public Services
Pete Dolack
Global Warming Will Accelerate as Oceans Reach Limits of Remediation
Franklin Lamb
34 Years After the Sabra-Shatila Massacre
Cesar Chelala
How One Man Held off Nuclear War
Norman Pollack
Sovereign Immunity, War Crimes, and Compensation to 9/11 Families
Lamont Lilly
Standing Rock Stakes Claim for Sovereignty: Eyewitness Report From North Dakota
Barbara G. Ellis
A Sandernista Priority: Push Bernie’s Planks!
Hiroyuki Hamada
How Do We Dream the Dream of Peace Together?
Russell Mokhiber
From Rags and Robes to Speedos and Thongs: Why Trump is Crushing Clinton in WV
Julian Vigo
Living La Vida Loca
Aidan O'Brien
Where is Europe’s Duterte? 
Abel Cohen
Russia’s Improbable Role in Everything
Ron Jacobs
A Change Has Gotta’ Come
Uri Avnery
Shimon Peres and the Saga of Sisyphus
Graham Peebles
Ethiopian’s Crying out for Freedom and Justice
Robert Koehler
Stop the Killing
Thomas Knapp
Election 2016: Of Dog Legs and “Debates”
Yves Engler
The Media’s Biased Perspective
Victor Grossman
Omens From Berlin
Christopher Brauchli
Wells Fargo as Metaphor for the Trump Campaign
Nyla Ali Khan
War of Words Between India and Pakistan at the United Nations
Tom Barnard
Block the Bunker! Historic Victory Against Police Boondoggle in Seattle
James Rothenberg
Bullshit Recognition as Survival Tactic
Ed Rampell
A Tale of Billionaires & Ballot Bandits
Kristine Mattis
Persnickety Publishing Pet-Peeves
Charles R. Larson
Review: Helen Dewitt’s “The Last Samurai”
David Yearsley
Torture Chamber Music
September 22, 2016
Dave Lindorff
Wells Fargo’s Stumpf Leads the Way
Stan Cox
If There’s a World War II-Style Climate Mobilization, It has to Go All the Way—and Then Some
Binoy Kampmark
Source Betrayed: the Washington Post and Edward Snowden
John W. Whitehead
Wards of the Nanny State
FacebookTwitterGoogle+RedditEmail